Home ›
Trademark Categories ›
Pharmaceuticals ›
2002 ›
PE ›
PERLEGEN
Trademark search for:
PERLEGEN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2006-04-07 — Application filed
2006-04-12 — Application filed
2006-04-13 — Notice of design search code mailed
2006-09-18 — Assigned to examiner
2006-10-03 — Examiners amendment -written
2006-10-03 — Approved for pub - principal register
2006-10-03 — Examiners amendment e-mailed
2006-10-03 — Examiner's amendment entered
2006-10-06 — Assigned to lie
2006-10-12 — Law office publication review completed
2006-11-15 — Notice of publication
2006-12-05 — Published for opposition
2007-02-27 — Noa mailed - sou required from applicant
2007-07-25 — Sou teas extension received
2007-07-25 — Sou extension 1 filed
2007-09-14 — Sou extension 1 granted
2008-02-04 — Sou teas extension received
2008-02-04 — Sou extension 2 filed
2008-02-21 — Sou extension 2 granted
2008-06-06 — Sou teas extension received
2008-06-06 — Sou extension 3 filed
2008-06-12 — Sou extension 3 granted
2009-03-30 — Application abandoned
2009-03-30 — Application abandoned
2009-03-30 — Final status recorded
2010-03-11 — Attorney/dom.rep.revoked and/or appointed
2010-03-11 — Teas revoke/app/change addr of atty/dom rep received
Owner Information
Perlegen Sciences, Inc.
Mountain View , CA
Perlegen Sciences, Inc.
Mountain View , CA
Correspondent
Bryan Walser, MD 309 University Drive Menlo Park, CA 94025 UNITED STATES
Filing Details
Filing Date:
2006-04-07
Status Date:
2009-03-30
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.